You are here Journals » Open Access Rheumatology: Research and Reviews » Volume 3
Review
Combination therapy versus celecoxib, a single selective COX-2 agent, to reduce gastrointestinal toxicity in arthritic patients: patient and cost-effectiveness considerations
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 14,504 | Dovepress* | 11,828 | 4,683 | 16,511 | |
| PubMed Central* | 2,676 | 148 | 2,824 | ||
| Totals | 14,504 | 4,831 | 19,335 | ||
|
*Since 4 August 2011 +Since July 2016 |
|||||
View citations on PubMed and Google Scholar